IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?
FBT delivered 57.7% returns over one year but with nearly double the maximum drawdown. IYH offers lower costs and steadier performance for risk-averse investors.
Overview
The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad, low-cost exposure to the domestic healthcare sector, whereas the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers a high-conviction, more volatile play on biotechnology.
Both funds target the U.S. healthcare market but use different weighting strategies and sub-sector concentrations. This comparison explores how their divergent approaches to the healthcare landscape affect their risk profiles, costs, and historical performance.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yearr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Details
Source
Originally published at www.fool.com.
Related Articles
- Easing inflation pressures, Cerebras earnings, falling Hormuz traffic and more in Morning Squawk
- Celsius (CELH) Q2 2026 Earnings Call Transcript
- Marc Benioff's Salesforce Spent a Record $27 Billion on Stock Buybacks in a Single Quarter to Fight What He Calls the "SaaSpocalypse." Here's Why the Size of That Repurchase Matters.